#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
18	52229980	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.4194;groupNumber2
18	52230253	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.4857;groupNumber2
18	55073885	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.4783;groupNumber3
18	55073907	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.5;groupNumber3
9	15824447	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.1;groupNumber4
9	15824450	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1;groupNumber4
17	12247658	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2609;groupNumber5
17	12247689	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2712;groupNumber5
17	12247875	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2809;groupNumber5
17	12248574	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.6286;groupNumber5
17	12248696	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.6732;groupNumber5
17	12248833	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.569;groupNumber5
17	12248871	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.569;groupNumber5
17	27429426	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.25;groupNumber7
17	27429730	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber7
11	60078783	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4133;groupNumber10
11	60078904	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4444;groupNumber10
11	67073109	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.25;groupNumber13
11	67073379	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber13
11	71612804	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.1463;groupNumber15
11	71612806	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.1446;groupNumber15
11	90276686	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.5;groupNumber16
11	90276982	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4583;groupNumber16
12	43742018	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.5312;groupNumber20
12	43742039	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.5333;groupNumber20
12	78786308	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.3214;groupNumber21
12	78786312	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber21
14	23430382	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.5652;groupNumber23
14	23430514	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.625;groupNumber23
14	48344022	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.2093;groupNumber24
14	48344090	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2941;groupNumber24
5	20209997	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1212;groupNumber27
5	20209999	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.1176;groupNumber27
5	88885690	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.381;groupNumber30
5	88885706	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.3704;groupNumber30
5	89460073	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3929;groupNumber31
5	89460197	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.4815;groupNumber31
5	121276830	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.24;groupNumber33
5	121276840	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.2667;groupNumber33
5	149943277	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.44;groupNumber34
5	149943561	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.4118;groupNumber34
5	149943564	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.4737;groupNumber34
5	150115712	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3548;groupNumber35
5	150115716	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.3226;groupNumber35
5	150285202	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.4091;groupNumber36
5	150285221	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3462;groupNumber36
5	174798690	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.5405;groupNumber37
5	174798698	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.6;groupNumber37
19	3634886	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.6364;groupNumber39
19	3634892	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.7143;groupNumber39
19	58678155	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.2391;groupNumber42
19	58678160	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2174;groupNumber42
20	50372483	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.15;groupNumber43
20	50372924	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.1698;groupNumber43
15	40967896	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.5;groupNumber44
15	40967915	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4286;groupNumber44
13	70302773	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.4516;groupNumber45
13	70302837	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.4762;groupNumber45
X	15429073	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.215;groupNumber46
X	15429355	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.1417;groupNumber46
X	17481817	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.4643;groupNumber48
X	17482006	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4118;groupNumber48
X	39552562	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.1833;groupNumber49
X	39553039	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.2027;groupNumber49
X	55623900	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.3636;groupNumber50
X	55624180	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.4634;groupNumber50
X	82519129	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.475;groupNumber51
X	82519278	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.5;groupNumber51
X	82519279	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4848;groupNumber51
X	97797946	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4667;groupNumber52
X	97797975	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.375;groupNumber52
X	102565311	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3846;groupNumber53
X	102565748	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber53
X	102567153	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3902;groupNumber53
X	102567623	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3235;groupNumber53
X	141748207	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.4545;groupNumber55
X	141748328	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.5116;groupNumber55
3	87557356	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.3148;groupNumber58
3	87557359	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.3137;groupNumber58
3	132589849	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.8261;groupNumber60
3	132589852	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.8409;groupNumber60
3	143478967	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.973;groupNumber61
3	143478970	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.9737;groupNumber61
4	44956991	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.1702;groupNumber63
4	44957055	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.2593;groupNumber63
4	47997615	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.3721;groupNumber64
4	47997623	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3171;groupNumber64
4	62649539	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.3167;groupNumber66
4	62649853	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.2308;groupNumber66
4	80705696	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.2258;groupNumber68
4	80706105	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3256;groupNumber68
4	89057060	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.2973;groupNumber69
4	89057282	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.3158;groupNumber69
4	115970634	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.3333;groupNumber70
4	115970867	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3396;groupNumber70
4	163932835	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.4595;groupNumber72
4	163932837	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4167;groupNumber72
4	175548766	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.3529;groupNumber73
4	175548781	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.4062;groupNumber73
21	11073001	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.125;groupNumber74
21	11073052	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.0946;groupNumber74
6	292992	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1961;groupNumber75
6	293108	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1579;groupNumber75
6	293219	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1863;groupNumber75
6	299510	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.172;groupNumber75
6	299608	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1538;groupNumber75
6	302802	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2034;groupNumber75
6	303305	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1329;groupNumber75
6	309525	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2102;groupNumber75
6	309939	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1847;groupNumber75
6	313538	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1758;groupNumber75
6	313769	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1546;groupNumber75
6	3114173	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2143;groupNumber76
6	3114216	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1316;groupNumber76
6	15847138	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1875;groupNumber77
6	15847485	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1062;groupNumber77
6	64271674	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.0585;groupNumber82
6	64271727	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.069;groupNumber82
6	65020930	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.125;groupNumber84
6	65020951	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.125;groupNumber84
6	65951921	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.566;groupNumber85
6	65951924	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.5636;groupNumber85
6	101992358	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4262;groupNumber86
6	101992373	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.3939;groupNumber86
6	106415852	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.5854;groupNumber87
6	106415861	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.5385;groupNumber87
1	72404624	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2558;groupNumber90
1	72405032	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.3056;groupNumber90
1	103384942	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.283;groupNumber91
1	103385066	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.28;groupNumber91
1	105588704	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.1639;groupNumber92
1	105589138	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.1538;groupNumber92
1	116420410	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.5017;groupNumber94
1	116420414	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.5017;groupNumber94
1	116584861	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.0278;groupNumber95
1	116584903	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.0405;groupNumber95
1	120502391	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.0536;groupNumber98
1	120502413	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.059;groupNumber98
1	226801953	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1196;groupNumber101
1	226801960	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.1163;groupNumber101
1	226801969	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.1628;groupNumber101
22	19271816	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.0435;groupNumber103
22	19271818	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.0426;groupNumber103
22	41650402	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1111;groupNumber105
22	41650408	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.1111;groupNumber105
2	18502222	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.093;groupNumber106
2	18502224	BRCA-UK_SP116353	G	A	.	.	ClusteredAnalysis;VAF=0.0698;groupNumber106
2	20899306	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2083;groupNumber107
2	20899455	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.2097;groupNumber107
2	62539085	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4074;groupNumber108
2	62539113	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.4545;groupNumber108
2	62539195	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.6111;groupNumber108
2	62539221	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.6667;groupNumber108
2	138307326	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.1034;groupNumber112
2	138307328	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.0847;groupNumber112
2	161889549	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1452;groupNumber113
2	161889564	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1897;groupNumber113
7	5601368	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4;groupNumber116
7	5601389	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.4286;groupNumber116
7	89502590	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.1471;groupNumber120
7	89502912	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2237;groupNumber120
7	97751151	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.1795;groupNumber121
7	97751543	BRCA-UK_SP116353	G	T	.	.	ClusteredAnalysis;VAF=0.1345;groupNumber121
8	47888945	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.1186;groupNumber125
8	47888948	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.126;groupNumber125
8	88281808	BRCA-UK_SP116353	C	T	.	.	ClusteredAnalysis;VAF=0.2245;groupNumber128
8	88281856	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1413;groupNumber128
8	139139124	BRCA-UK_SP116353	C	G	.	.	ClusteredAnalysis;VAF=0.1351;groupNumber129
8	139139158	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1193;groupNumber129
8	139675696	BRCA-UK_SP116353	A	C	.	.	ClusteredAnalysis;VAF=0.1538;groupNumber130
8	139675733	BRCA-UK_SP116353	A	T	.	.	ClusteredAnalysis;VAF=0.1081;groupNumber130
16	56456934	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.1724;groupNumber132
16	56456936	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.1875;groupNumber132
10	49399747	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2653;groupNumber134
10	49399836	BRCA-UK_SP116353	T	C	.	.	ClusteredAnalysis;VAF=0.2174;groupNumber134
10	58521269	BRCA-UK_SP116353	T	A	.	.	ClusteredAnalysis;VAF=0.2;groupNumber135
10	58521271	BRCA-UK_SP116353	T	G	.	.	ClusteredAnalysis;VAF=0.1944;groupNumber135
10	74857901	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2619;groupNumber136
10	74857904	BRCA-UK_SP116353	A	G	.	.	ClusteredAnalysis;VAF=0.2857;groupNumber136
10	89021737	BRCA-UK_SP116353	G	C	.	.	ClusteredAnalysis;VAF=0.25;groupNumber137
10	89021747	BRCA-UK_SP116353	C	A	.	.	ClusteredAnalysis;VAF=0.2333;groupNumber137
